浙江中西医结合杂志
浙江中西醫結閤雜誌
절강중서의결합잡지
ZHEJIANG JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2013年
11期
876-878,882
,共4页
轻度认知功能损害%阿尔茨海默病%银杏叶提取物
輕度認知功能損害%阿爾茨海默病%銀杏葉提取物
경도인지공능손해%아이자해묵병%은행협제취물
mild cognitive impairment%Alzheimer's disease%ginkgo biloba extract
目的:观察银杏叶提取物对轻度认知功能损害(MCI)的影响。方法:MCI患者245例,随机分为治疗组(n=123)与对照组(n=122),两组均予基础治疗,治疗组加用银杏叶提取物40mg,1天3次,口服。两组治疗前、治疗6个月及1年行简易精神状态检查(MMSE)与画钟试验(CDT)。监测治疗前后两组红细胞乙酰胆碱(RBC-Ach)及红细胞乙酰胆碱酯酶(RBC-AchE)活性。结果:治疗6个月及1年,治疗组MMSE、CDT积分均显著提高,且均高于同期对照组(P<0.01);与治疗前比较,治疗1年治疗组RBC-Ach含量显著升高(P<0.01),且高于对照组(P<0.01);治疗组RBC-AchE活性水平显著下降(P<0.01),且低于对照组(P<0.01)。结论:银杏叶提取物能显著改善MCI患者认知功能,降低AD转化率,可能与其改善中枢胆碱能系统功能有关。
目的:觀察銀杏葉提取物對輕度認知功能損害(MCI)的影響。方法:MCI患者245例,隨機分為治療組(n=123)與對照組(n=122),兩組均予基礎治療,治療組加用銀杏葉提取物40mg,1天3次,口服。兩組治療前、治療6箇月及1年行簡易精神狀態檢查(MMSE)與畫鐘試驗(CDT)。鑑測治療前後兩組紅細胞乙酰膽堿(RBC-Ach)及紅細胞乙酰膽堿酯酶(RBC-AchE)活性。結果:治療6箇月及1年,治療組MMSE、CDT積分均顯著提高,且均高于同期對照組(P<0.01);與治療前比較,治療1年治療組RBC-Ach含量顯著升高(P<0.01),且高于對照組(P<0.01);治療組RBC-AchE活性水平顯著下降(P<0.01),且低于對照組(P<0.01)。結論:銀杏葉提取物能顯著改善MCI患者認知功能,降低AD轉化率,可能與其改善中樞膽堿能繫統功能有關。
목적:관찰은행협제취물대경도인지공능손해(MCI)적영향。방법:MCI환자245례,수궤분위치료조(n=123)여대조조(n=122),량조균여기출치료,치료조가용은행협제취물40mg,1천3차,구복。량조치료전、치료6개월급1년행간역정신상태검사(MMSE)여화종시험(CDT)。감측치료전후량조홍세포을선담감(RBC-Ach)급홍세포을선담감지매(RBC-AchE)활성。결과:치료6개월급1년,치료조MMSE、CDT적분균현저제고,차균고우동기대조조(P<0.01);여치료전비교,치료1년치료조RBC-Ach함량현저승고(P<0.01),차고우대조조(P<0.01);치료조RBC-AchE활성수평현저하강(P<0.01),차저우대조조(P<0.01)。결론:은행협제취물능현저개선MCI환자인지공능,강저AD전화솔,가능여기개선중추담감능계통공능유관。
Objective:To observe the therapeutic effect of Ginkgo biloba extract on mild cognitive impairment(MCI). Methods:A total of 245 MCI patients were randomly divided into treatment group (n=123) and control group (n=122). Both groups received basal therapy and the treatment group was given 40 mg Ginkgo biloba extract orally,3 times per day in addition. Mini-mental state examination(MMSE) and clock drawing task(CDT) were carried out to examine the patient's mental state before and half a year and 1 year after treatment. Serum RBC-Ach and RBC-AchE were determined in both groups before and after treatment. Results:In half a year and 1 year treatment,the patient in treatment group had higher scores in MMSE and CDT compared with control group at each time point (all P<0.01). Compared with that before treatment and that in control group,RBC-Ach was higher and RBC-AchE was lower in patients in treatment group after 1-year treatment (all P<0.01). Conclusion:Ginkgo biloba extract can improve cognitive activity and reduce the conversion rate of MCI to Alzheimer's disease in patients with MCI,which may be realized by regulating central cholinergic system.